Type 2 immune response pathway (TRAF3IP2 and BCL6) plays an important role in AD pathology such as amyloid deposition (Marsh et al., 2016; Van Hoecke et al., 2024). This evidence concerns the gene TRAF3IP2 and Alzheimer disease.